Real‐World Outcomes of Telemedicine Shared Medical Appointments in Obesity Management

ABSTRACT Introduction Shared Medical Appointments (SMAs) have recently emerged as a novel tool in weight management as they are efficient, bypass logistic barriers to physical attendance, decrease attrition, and are cost‐effective. This study aimed to observe outcomes among patients enrolled in an insurance‐based weight loss program, called Program for Reducing Obesity (PRO), utilizing telemedicine SMAs during a 12 month period of chronic weight management. Methods Patients of age ≥ 18 years with BMI ≥ 30 kg/m 2 were enrolled in the program, consisting of telemedicine SMAs with an obesity medicine board‐certified physician and a registered dietitian. The primary outcome was the change in body weight at 6 and 12 months. Secondary outcomes were changes in glycated hemoglobin (HgbA1c) and triglyceride (TG) levels. Results One hundred and nine patients, who had been enrolled in the program for about 18 months, were included in the study. The mean age was 62.40 ± 12.5 years. 73% were treated with obesity management medications. Patients attended an average of 10 classes through SMAs. 51% of patients had prediabetes, and 25% had Type 2 Diabetes Mellitus (DM). The mean weight of patients at baseline was 97.54 ± 19 kg, with an average weight loss of 2.38 ± 4.78 kg (2.43%) and 4.47 ± 7.77 kg (4.55%) at 6 and 12 months ( p < 0.001). The mean baseline HgbA1c and TG levels were 5.96 ± 0.8% and 137.43 ± 112.4 mg/dL, respectively. HgbA1c levels decreased by 0.11 ± 0.65 (2.19%) and 0.20 ± 0.50 (3.70%) at 6 and 12 months, and TG levels decreased by 25.19 ± 104.60 mg/dL (33.60%) at 6 months and 35.83 ± 112.08 mg/dL (41.14%) at 12 months ( p < 0.05). There were no statistically significant differences in weight loss between sexes, and regardless of the presence of DM, use of obesity management medications, or the number of classes attended. Conclusion This study showed that telemedicine SMAs are an effective and efficient method for promoting weight loss, even in the ongoing maintenance phase.

Authors

Institutions

Publication Details

Journal
Obesity Science & Practice
Published
2026-09-17
DOI
https://doi.org/10.1002/osp4.70197
Primary Topic
Mobile Health and mHealth Applications
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Real‐World Outcomes of Telemedicine Shared Medical Appointments in Obesity Management

Na Shen, Nicholas Jackson, Derek Pham, Jeffrey Wei et al.
Obesity Science & Practice
Mobile Health and mHealth Applications
article

Real‐World Outcomes of Telemedicine Shared Medical Appointments in Obesity Management

Na Shen, Nicholas Jackson, Derek Pham, Jeffrey Wei, Lei Lei, Keerthana Haridas
article en

Abstract

ABSTRACT Introduction Shared Medical Appointments (SMAs) have recently emerged as a novel tool in weight management as they are efficient, bypass logistic barriers to physical attendance, decrease attrition, and are cost‐effective. This study aimed to observe outcomes among patients enrolled in an insurance‐based weight loss program, called Program for Reducing Obesity (PRO), utilizing telemedicine SMAs during a 12 month period of chronic weight management. Methods Patients of age ≥ 18 years with BMI ≥ 30 kg/m 2 were enrolled in the program, consisting of telemedicine SMAs with an obesity medicine board‐certified physician and a registered dietitian. The primary outcome was the change in body weight at 6 and 12 months. Secondary outcomes were changes in glycated hemoglobin (HgbA1c) and triglyceride (TG) levels. Results One hundred and nine patients, who had been enrolled in the program for about 18 months, were included in the study. The mean age was 62.40 ± 12.5 years. 73% were treated with obesity management medications. Patients attended an average of 10 classes through SMAs. 51% of patients had prediabetes, and 25% had Type 2 Diabetes Mellitus (DM). The mean weight of patients at baseline was 97.54 ± 19 kg, with an average weight loss of 2.38 ± 4.78 kg (2.43%) and 4.47 ± 7.77 kg (4.55%) at 6 and 12 months ( p < 0.001). The mean baseline HgbA1c and TG levels were 5.96 ± 0.8% and 137.43 ± 112.4 mg/dL, respectively. HgbA1c levels decreased by 0.11 ± 0.65 (2.19%) and 0.20 ± 0.50 (3.70%) at 6 and 12 months, and TG levels decreased by 25.19 ± 104.60 mg/dL (33.60%) at 6 months and 35.83 ± 112.08 mg/dL (41.14%) at 12 months ( p < 0.05). There were no statistically significant differences in weight loss between sexes, and regardless of the presence of DM, use of obesity management medications, or the number of classes attended. Conclusion This study showed that telemedicine SMAs are an effective and efficient method for promoting weight loss, even in the ongoing maintenance phase.

Obesity Science & PracticeVol. 12(5)
University of California, Los Angeles (US)
Openalex Percentile: Top 6%
Mobile Health and mHealth Applications
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.